Joaquin Duato - Feb 7, 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Joaquin Duato
Stock symbol
JNJ
Transactions as of
Feb 7, 2025
Transactions value $
-$15,410,456
Form type
4
Date filed
2/11/2025, 07:43 PM
Previous filing
Feb 20, 2024
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $12.6M +126K +34.78% $100.06 490K Feb 7, 2025 Direct F1
transaction JNJ Common Stock Tax liability -$15.4M -101K -20.55% $153.12 389K Feb 7, 2025 Direct F2
holding JNJ Common Stock 946 Feb 7, 2025 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise -$12.6M -126K -100% $100.06 0 Feb 7, 2025 Common Stock 126K $100.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the auto-exercise of options immediately prior to their expiration.
F2 Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).